| Genetic susceptibility to endometrial cancer risk in PLCO |
Nicolas Wentzensen MD |
NCI, DCEG, HREB |
PLCO |
Mar 1, 2010 |
2010-0050 |
| Metabolomic profiles as predictors of colorectal cancer risk |
Rashmi Sinha |
NCI/DCEG |
PLCO |
Mar 1, 2010 |
2010-0047 |
| A genome-wide association study of non-Hodgkin lymphoma |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Mar 1, 2010 |
2010-0008 |
| Contribution to consortial activities for clarifying the etiology of male breast cancers |
Louise Brinton |
NCI, DCEG, HREB |
PLCO |
Jan 28, 2010 |
2008-0252 |
| Screen for Rare Alleles by Deep Resequencing of Colorectal Cancer Cases |
Ulrike Peters |
Fred Hutchinson Cancer Research Center |
PLCO |
Jan 28, 2010 |
2009-0554 |
| Serum Estrogens and Subsequent Risk of Prostate Cancer |
Amanda Black |
NCI, DCEG, EBP |
PLCO |
Jan 28, 2010 |
2009-0562 |
| Identification of factors associated with development and progression of monoclonal B-cell lymphocytosis (MBL) |
Ola Landgren |
Sylvester Comprehensive Cancer Center, University of Miami |
PLCO |
Jan 21, 2010 |
2009-0561 |
| Serum IgE and Risk of Pancreatic Cancer |
Sara Olson |
Memorial Sloan-Kettering Cancer Center |
PLCO |
Jan 21, 2010 |
2009-0563 |
| A Mendelian randomization study of diabetes mellitus and prostate cancer risk |
Brandon Pierce |
University of Chicago |
PLCO |
Jan 21, 2010 |
2009-0094 |
| Modifying Effects of Variant Oxidative Stress Related Genes in Relation to Prostate Cancer Outcomes |
LaCreis Kidd |
University of Louisville |
PLCO |
Jan 21, 2010 |
2009-0244 |
| Risk of renal cell carcinoma in relation to telomere length and mtDNA copy number in peripheral blood lymphocytes |
Jonathan Hofmann |
NCI, DCEG, OEEB |
PLCO |
Dec 15, 2009 |
2009-0549 |
| Association of Human Endogenous Retrovirus K (HERV-K) Expression with Prostate Cancer Development and Progression |
Stefan Ambs |
- |
PLCO |
Dec 15, 2009 |
2009-0552 |
| Serum Creatinine and Prostate Cancer Risk in the PLCO Study |
Stephanie Weinstein |
DCEG - NEB |
PLCO |
Dec 15, 2009 |
2009-0555 |
| Markers of susceptibility to ovarian cancer risk and survival in PLCO |
Nicolas Wentzensen MD |
NCI, DCEG, HREB |
PLCO |
Dec 15, 2009 |
2009-0558 |
| DNA Methylation Markers and Prostate Cancer Risk |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Dec 15, 2009 |
2009-0564 |
| Serum Sarcosine, Variation in Sarcosine-related Genes and Subsequent Risk of Prostate Cancer |
Stella Koutros |
NCI, DCEG, OEEB |
PLCO |
Dec 15, 2009 |
2009-0565 |
| Reconciling Results of PSA Screening Efficacy Using PLCO and ERSPC data: CISNET modeling project |
Angela Mariotto |
NCI, DCCPS, DMB |
PLCO |
Nov 12, 2009 |
2009-0182 |
| New statistical approaches for adjusting seasonal variation in vitamin D concentration measurement, with application in the PLCO nested case-control study of serum vitamin D concentration and prostate cancer risk |
Kai Yu |
NCI, DCEG, BB |
PLCO |
Nov 11, 2009 |
2009-0006 |
| Trichomonosis and prostate cancer risk in the Prostate, Lung, Colorectal & Ovarian Cancer Screening Trial |
Siobhan Sutcliffe |
Washington University |
PLCO |
Nov 9, 2009 |
2009-0556 |
| Telemore length and risk of glioma |
Preetha Rajaraman |
NCI, DCEG, REB |
PLCO |
Nov 9, 2009 |
2009-0557 |
